Subcutaneous injection of triamcinolone acetonide into the eyelid for vernal keratoconjunctivitis Masahiko Kozawa 1 , Akio Yamaguchi 1 , Aki Fuchigami 1 , Kazuaki Kadonosono 2 , Eiichi Uchio 1 1Dept of Ophthalmol, Fukuoka Univ Sch of Med 2Dept of Ophthalmol, Yokohama City Univ Med Cent pp.739-743
Published Date 2007/5/15
DOI https://doi.org/10.11477/mf.1410101618
  • Abstract
  • Look Inside
  • Reference

Abstract. Purpose:To report the outcome of subcutaneous injection of triamcinolone acetonide(TA)into the eyelid of patients with severe vernal keratoconjunctivitis(VKC). Cases and Method:This study was made in 2 institutions during a 62-month period. TA was injected into the eyelid of 28 eyes of 20 male patients in a single session. Their age ranged from 7 to 34 years, average 15 years. Another group of 8 eyes of 8 male patients received peroral prednisolone. Their age ranged from 8 to 28 years, average 15 years. Severity of VKC was expressed as score after the clinical diagnosis criteria. Results:Clinical manifestations improved in both groups 2 weeks after treatment. The group treated by injection showed significantly better improvement than perorally treated group after 24 weeks(p<0.01). Elevation of intraocular pressure was absent throughout. Conclusion:A single injection of TA into the eyelid induces prompt and lasting effect in patients with severe VKC.

Copyright © 2007, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院